findmyKOL

Jeffrey Brown, MD

Basic profile

Endocrinology, Diabetes & Metabolism

ORCIDNone on fileNPI
RegionHouston, TX · South CentralSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jeffrey Brown is an Endocrinology/Metabolic physician.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
42companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

909 Dairy Ashford St
Suite 205
Houston, TX 77079

Telephone

281-589-2694

Provider last certified this registry record 10 Dec 2020.

View the NPPES registry record

Industry payments

42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    60.5%
    l-Thyroxine58.4%
    Synthroid61%Tirosint14%Levoxyl12%Unithroid11%Levothyroxine Sodium1%Tirosint-Sol1%
    Part D<11 patients
    l-Triiodothyronine1.1%
    Liothyronine Sodium100%
    Part D12 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    21.9%
    Biguanide (metformin)4.7%
    Metformin Hcl Er55%Metformin Hcl37%Metformin Er Gastric8%
    Part D<11 patients
    Provitamin D2 Compound3.8%
    Vitamin D2100%
    Part D35 patients

    + 7 more classes in this area

  • Cardiovascular

    9.1%
    Statin5.4%
    Rosuvastatin Calcium51%Atorvastatin Calcium37%Simvastatin12%
    Part D<11 patients
    Cholesterol absorption inhibitor1.8%
    Ezetimibe100%
    Part D14 patients

    + 2 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”